Novavax Succeeds In Phase III Flu Vaccine Trial Against Sanofi’s Fluzone

 
• By Joseph Haas
Injection
Novavax Phase III data may position it to file seasonal flu vaccine at FDA this year

More from Clinical Trials

More from R&D